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Spermatogonial stem cells can convert into embryonic stem (ES) cell-like multipotent germline stem (mGS) cells in vitro and produce germline
chimeras by blastocyst microinjection. Although homologous recombination was previously demonstrated in mGS cells, spermatogenesis was not
found in chimeras, suggesting that they are not competent for germline modification. Here we conducted detailed analysis of chimeric animals to
determine whether mGS cells retain germline potential after genetic manipulation. Spermatozoa that were deficient in the occludin gene could be
recovered from animals that were chimeric with mGS cells that underwent homologous recombination. The phenotypes of the occludin knockout
(KO) mice were similar to those reported for KO mice produced using ES cells, and the animals showed growth retardation, gastritis and male
infertility. Furthermore, we found that heterozygous mGS cells acquire two copies of the G418-resistant genes and become homozygous for the
targeted allele by culturing at high concentrations of G418. Cytogenetic analysis showed that the aneuploid mGS cells observed during genetic
manipulation were trisomic for chromosome 8 or 11, which is a common chromosomal abnormality in ES cells. Thus, mGS cells can be used to
produce KO animals, and this novel method of germline manipulation may prove useful in diverse mammalian species.
© 2007 Elsevier Inc. All rights reserved.Keywords: Stem cell; Spermatogenesis; Pluripotency; Germ cell; Gene targeting; MicroinseminationIntroduction
Germline cells are unique in that they transmit genetic
information from parent to offspring (de Rooij and Russell,
2000; Meistrich and van Beek, 1993). In the postnatal period,
only male germ cells initiate mitosis to become spermatogonial
stem cells. These cells self-renew and also produce progenitor
cells that eventually mature into spermatozoa. Female germline
cells stop dividing after birth in most species, whereas⁎ Corresponding author. Fax: +81 75 751 4169.
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doi:10.1016/j.ydbio.2007.09.029spermatogonial stem cells continue to proliferate and support
spermatogenesis throughout life in males.
Although germ cells are normally committed to producing
mature gametes, several studies have shown that these cells are
able to change their fate and convert into pluripotent cell types
under certain conditions. Primordial germ cells (PGCs)
originate from the epiblast 7.5 days postcoitum (dpc) in mice
(McLaren, 2003). These cells actively proliferate and migrate to
the genital ridge in the middle of the gestation. By 11.5 dpc,
most germ cells are located at the genital ridge, and female germ
cells enter meiosis by 13.5 dpc. In contrast, by then male germ
cells become proliferating gonocytes in the seminiferous cords,
and the gonocytes stop proliferating at about 16 dpc. Between
8.5 and 12.5 dpc, mouse embryo PGCs can convert into
345M. Takehashi et al. / Developmental Biology 312 (2007) 344–352pluripotent stem cells, known as embryonic germ (EG) cells,
when they are cultured in the presence of stem cell factor (SCF),
leukemia inhibitory factor (LIF) and basic fibroblast growth
factor (bFGF) (Matsui et al., 1992; Resnick et al., 1992). The
phenotype and differentiation capacity of these cells are similar
to those of ES cells derived from the inner cell mass (Evans and
Kaufman, 1981; Martin, 1981). EG cells form embryoid bodies
and produce differentiated somatic cell types. They also
contribute to embryonic development and produce germline
chimeras when microinjected into blastocysts (Labosky et al.,
1994; Stewart et al., 1994). These studies demonstrated for the
first time that germline cells can de-differentiate and acquire
pluripotency. EG cells have also been derived from non-murine
species, including humans (Shim et al., 1997; Shamblott et al.,
1998; Park and Han, 2000); however, since EG cells could not
be derived from germline cells at later developmental stages, it
has been suggested that pluripotency is lost during the late fetal
stage.
The characteristics of EG cells suggest that they may be
used as vehicles for germline transgenesis in a manner similar
to ES cells. However, there are no reports of the production
of knockout (KO) mice using EG cells. The reason for this
failure is unclear, but it may be related to genomic imprinting
since the only difference between ES and EG cells is the
genomic imprinting pattern; the level of site-specific
methylation for certain imprinted genes is reduced in EG
cells derived from embryos 11.5 and 12.5 dpc (Labosky et
al., 1994; Tada et al., 1998). Since genomic imprinting plays
an important role in regulating the differentiation capacity of
the cell, pluripotent cells derived from committed germ cells
may be less stable than ES cells in terms of their germline
potential.
We previously showed that spermatogonial stem cells from
postnatal testes could be expanded over the long-term in vitro
under culture conditions that included glial cell line-derived
neurotrophic factor (GDNF), LIF, bFGF and epidermal growth
factor (Kanatsu-Shinohara et al., 2003). These cultured cells,
called germline stem (GS) cells, continued to proliferate for at
least 2 years in vitro, and they maintained their capacity to
produce normal sperm and fertile offspring after transplantation
into testes (Kanatsu-Shinohara et al., 2005a). GS cells exhibit
the characteristics of spermatogonial stem cells, and they are
not pluripotent. Surprisingly, however, we recently found that
ES cell-like pluripotent stem cells appeared in a GS cell culture
during the establishment phase from neonatal testes (Kanatsu-
Shinohara et al., 2004a). Similar to ES/EG cells, these ES-like
cells, which we designated as multipotent germline stem
(mGS) cells, not only formed teratomas in vivo, but also
differentiated into a variety of somatic cell types in vitro. The
cells also produced germline chimeras by microinjection into
blastocysts, demonstrating that pluripotency persists in these
postnatal germ cells. Although several lines of evidence
suggest that both cell types originated from spermatogonial
stem cells, mGS cells cannot undergo spermatogenesis in the
testis, while GS cells produce sperm in the testis but do not
contribute to embryonic development (Kanatsu-Shinohara and
Shinohara, 2006).Since GS and mGS cells can both be manipulated in vitro
and produce offspring, the recent development of stem cell
culture techniques for these cell types opens up new
possibilities for germline transgenesis. Recently, we succeeded
in producing KO mice by gene trapping and gene targeting
using GS cells, but we were unable to produce KO mice using
mGS cells (Kanatsu-Shinohara et al., 2006a). The mGS cells
that underwent homologous recombination failed to contribute
to the germline following blastocyst injection. The failure to
produce KO animals with EG and mGS cells suggests that
pluripotent stem cells derived from germ cells have lower
germline stability and limited potential for genetic modification.
Here we report the successful production of KO mice using
mGS cells. The phenotypes of the mice were similar to those
made by gene targeting in ES and GS cells.
Materials and methods
Cell culture
GS cells were cultured according to a previously established protocol
(Kanatsu-Shinohara et al., 2003), whereas mGS cells were cultured on mouse
embryonic fibroblasts (MEFs) in standard ES cell culture medium, which
consisted of Dulbecco's modified Eagle's medium/15% fetal calf serum and
103 U/ml LIF (ESGRO, Invitrogen, Carlsbad, CA)(Kanatsu-Shinohara et al.,
2004a). For selection of the double KO cells, GS and mGS cells were cultured
on MEFs with various concentrations of G418 (Wako, Osaka, Japan). The
selected clones were transferred to a 96-well plate and expanded for DNA
analysis. G418 resistance was assessed by plating 3×104 cells on G418-resistant
MEFs in a 12-well culture plate, and the number of surviving colonies was
counted after 2 weeks of selection with 20 mg/ml G418. Embryoid bodies were
produced by culturing mGS cells on bacterial dishes in the absence of LIF, as
described previously (Saitou et al., 1998).
Transplantation
For teratoma formation, approximately 4×106 double KO mGS cells were
injected subcutaneously into KSN nude mice (Japan SLC, Shizuoka, Japan).
The teratomas were recovered at 4–6 weeks after transplantation and analyzed
by histological section. The Institutional Animal Care and Use Committee of
Kyoto University approved all animal experimentation protocols.
Southern blot analysis
Genomic DNA was isolated by phenol/chloroform extraction, followed by
ethanol precipitation. DNA transfer and hybridization were performed as
described previously using probes for both exon 2 (internal) and intron 4
(external) probes (Kanatsu-Shinohara et al., 2005b, 2006a). The clones were
also examined by hybridization with a cDNA fragment of the neo gene
(nucleotides 187 to 804).
Combined bisulfite restriction analysis (COBRA)
The methylation status of the imprinted genes was assessed by COBRA, as
described previously (Kanatsu-Shinohara et al., 2005a). The polymerase chain
reaction (PCR) products were digested with restriction enzymes that recognize
the CpG motif. The intensity of the digested DNAwas quantified using Mac Bas
version 2.5 software (Fuji Photo Film, Tokyo, Japan).
Histological analysis
For histological analysis, the samples were fixed in 10% neutral buffered
formalin and processed for paraffin sectioning. All sections were stained with
hematoxylin and eosin.
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Western blot analysis
Total RNA was prepared using TRIzol Reagent (Invitrogen). For RT-PCR,
first strand cDNA was synthesized using Superscript™ II (RNase H− reverse
transcriptase, Invitrogen). PCR was performed using primers specific for the
mouse occludin gene, as described previously (Saitou et al., 1998).
For the Western blots, the samples were lysed by homogenization with ice-
cold lysis buffer (50 mM Tris–HCl, pH 6.8, 2% SDS, 20% glycerol, 2% 2-
mercaptoethanol, 0.01% bromophenol blue) supplemented with a protease
inhibitor cocktail (Sigma, St. Louis, MO). Whole-cell extracts were separated by
10% SDS–polyacrylamide gel electrophoresis, transferred to Hybond-P
membranes (Amersham Biosciences, Buckinghamshire, UK), blocked with
5% skim milk in Tris-buffered saline containing 0.1% Triton X-100 and probed
with rabbit polyclonal anti-mouse occludin antibody (a gift from Dr. S. Tsukita,
Kyoto University). Peroxidase-conjugated anti-rabbit IgG antibody (Cell
Signaling, Danvers, MA) was used as the secondary antibody, and the protein
bands were detected using the enhanced chemiluminescence detection method
(LumiGLO™; Cell Signaling).
Microinsemination
The seminiferous tubules of the chimeric animals were dissected under UV
light. Enhanced green fluorescent protein (EGFP)-expressing seminiferous
tubules were recovered, and the germ cells were collected mechanically using
fine forceps. Microinsemination was performed as described previously using
round spermatids (Kimura and Yanagimachi, 1995). Embryos that reached the
two-cell stage after 24 h of culture were transferred to the oviducts of day 1
pseudopregnant ICR female mice. Fetuses that were retrieved on day 19.5 were
raised by ICR foster mothers.
Chromosome analysis
The wild-type, heterozygous KO and double KO mGS cells harvested from
culture dishes were treated with 0.075 M KCl for 15 min and were fixed with
methanol/acetic acid (3:1). The chromosome slides were prepared using the
standard method. The slides were stained with quinacrine mustard and Hoechst
33258. At least 20 metaphase cells were karyotyped for each cell type. The
chromosomal aberrations, trisomic for chromosome 8 and/or 11, were confirmed
by fluorescence in situ hybridization (FISH) analysis using mouse chromosome
8- and 11-specific probes (TAKARA BIO, Otsu, Japan).
Results
Production of KO mice by in vitro microinsemination using
testicular sperm recovered from mGS chimeric mice
In a previous study, we generated chimeric animals using an
EGFP-expressingmGS cell clone (clone 118) that was targeted to
the mouse occludin gene locus (Kanatsu-Shinohara et al., 2006a)
(Figs. 1A–C). Of the 43 offspring (14 males and 29 females) that
matured into adults, we sacrificed seven males and 15 females.
Although we found EGFP-positive cells in the ovaries of two
females, we were not able to determine whether the mGS cells in
the ovaries that contributed to the germ cells, somatic cells, or
both. Furthermore, none of the seven males had contributions in
the germline, as shown by EGFP fluorescence (Kanatsu-
Shinohara et al., 2006a). We sacrificed the remaining seven
males to examine whether germline transmission had occurred
with themGS cells and found that the seminiferous tubules of one
of the animals showed EGFP fluorescence under UV light (Fig.
1D). This animal also had donor mGS cell contributions in its
heart, pancreas and other organs (data not shown).To generate offspring from this chimeric male, we used in
vitro microinsemination, a technique commonly used to
produce offspring in infertile animals and humans (Palermo et
al., 1992; Kimura and Yanagimachi, 1995). EGFP-expressing
seminiferous tubules were dissociated using fine forceps, and
the round spermatids thus recovered were used for in vitro
microinsemination (Figs. 1E and F). Of the 220 embryos
constructed, 67 developed to the two-cell stage, and these were
transferred into pseudopregnant ICR mothers. Ten offspring
were born, and nine developed into normal mature adults (four
males and five females). PCR analysis revealed that two of the
males and two of the females were heterozygous for the targeted
allele (Fig. 1G). COBRA revealed normal imprinting patterns in
the H19, Meg3 IG, Igf2r and Peg 10 regions in the offspring,
indicating that erasure and acquisition of the normal imprint had
occurred successfully during germline development in the
chimeric male (Fig. 1H).
To examine whether gene targeting in spermatogonial stem
cells influences the phenotypes of KO animals, we generated
two types of KO mice using mGS cells. One of the
heterozygous males was bred with heterozygous females
derived from gene targeting in GS cells (Kanatsu-Shinohara et
al., 2006a), while the other heterozygous male was crossed with
the heterozygous females produced from mGS cells. The
intercrosses between the heterozygous mGS KO male and the
GS KO females yielded offspring that segregated with the
expected Mendelian distribution: 12 wild-type, 23 heterozygous
and 9 homozygous mutant (mGS/GS KO) pups were obtained
from 6 litters. Likewise, intercrosses between the mGS
heterozygous offspring produced 14 wild-type, 29 heterozygous
and 9 homozygous mutant (mGS/mGS KO) pups in 8 litters.
The lack of occludin mRNA and protein was confirmed in both
types of KO mice (Figs. 1I and J). These results indicate that
mGS cells can be used to produce KO mice by homologous
recombination and germline transmission in a manner similar to
ES cells.
Phenotypes of the KO mice
Results from ES cell-based occludin gene-targeting experi-
ments demonstrated that homozygous occludin KO mice had
postnatal growth retardation but no gross macroscopic pheno-
type (Saitou et al., 1998; Saitou et al., 2000). In agreement with
these observations, both the mGS/mGS and mGS/GS KO mice
were normal in appearance, but they both showed growth
retardation. Growth retardation was observed in both the males
and females; both mGS/mGS and mGS/GS KO mice were
∼70% of the normal weight at 8 weeks of age (Fig. 2A).
Similarly, the homozygous KO mice produced by gene
targeting in GS cells (GS/GS KO) were ∼70% of the normal
weight at 8 weeks of age (Fig. 2A). Even at more mature stages,
the average weight of both types of KO mice was less than that
of the wild-type animals.
We then conducted histological analyses of several organs
from the KO mice. Previously, we found that the striated ducts
of the salivary glands of occludin KO (GS/GS KO) mice lacked
characteristic cytoplasmic granules (Kanatsu-Shinohara et al.,
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showed predominant hyperplasia and numerous lymphocytes
had infiltrated the gastric epithelium, indicating chronic gastritis
(Figs. 2D and E). Furthermore, the KO animals had osteoporo-
sis and exhibited significantly thinner trabeculae than did thewild-type animals (Figs. 2F and G). The animals also showed
other pathological features, such as calcification in the brain
(Figs. 2H and I). Similar abnormalities were found in all KO
mice groups (mGS/mGS, mGS/GS and GS/GS), which is
consistent with the findings in ES cell-based KO mice (Saitou et
al., 2000).
As the KO animals aged, their abnormalities gradually
worsened. All KO animals had regenerating gastric epithelia
due to constant inflammation. The most striking change,
however, was observed in the testes. Although normal
spermatogenesis was observed in young animals, germ cells
were progressively lost from the seminiferous tubules of older
animals (Figs. 3A–F). When the testes were examined 9 months
after birth, the number of spermatogenic cells was decreased
possibly due to decreased proliferation of the spermatogonial
stem cells, and only a small number of postmeiotic germ cells
were found in these animals (Fig. 3E). The epididymides of
these animals did not contain any spermatozoa (Fig. 3F), which
is consistent with previous observations in ES cell-based KO
animals (Saitou et al., 2000).
As expected from our histological findings, the male KO
mice either produced significantly smaller numbers of offspring
or were completely infertile. We analyzed the fertility of GS/GS
and mGS/mGS KO males by mating with wild-type females. In
the case of the GS/GS KO mice, while all three wild-type males
produced a total of 57 litters during a 6-month period, two of the
three KO males produced 3 litters. The number of litters
gradually decreased and the KO males were infertile when they
are older than 3 month of age (Fig. 3G). Likewise, while four
wild-type males produced a total of 19 litters, three of the four
mGS/mGS KO males produced a total of 3 litters during a 2-
month period. As with GS/GS KO males, the mGS/mGS KO
animals were able to produce offspring only when the animals
were less than 3 month old. In contrast, all female KO mice
were fertile, and germline transmission of the targeted allele was
confirmed in all groups (Fig. 1K).Fig. 1. Production of occludin KO mice using mGS cells. (A) Diagram of the
targeting strategy. B, BamHI; E, EcoRV; H, HindIII; N, NheI; P, PstI; X, XbaI.
P1 and P2 represent the primers used for PCR. (B, C) Appearance of the targeted
mGS cells (clone 118) (B), showing fluorescence under UV light (C). (D)
Macroscopic appearance of the testis from a chimeric animal. Several EGFP-
positive seminiferous tubules were found under UV illumination. (E, F)
Spermatogenic cells released from part of a segment of seminiferous tubule that
showed EGFP fluorescence. Nomarski (E) and fluorescent (F) images. The
arrowheads indicate the round spermatids that were used in microinsemination.
(G) PCR analysis of gene targeting in the offspring. Tail DNA samples were
analyzed by PCR to amplify a 2.4-kb fragment spanning the 3′ junction of the
targeted locus. (H) COBRA of genomic DNA from targeted mGS cells (clone
118) and F1 offspring derived from microinsemination. DNA methylation status
of the target locus. DNA was amplified using specific primers and the PCR
products were digested with the indicated restriction enzymes. The percentage of
methylation, estimated by the intensity of the individual bands, is indicated
below the gels. U, uncleaved; C, cleaved. (I, J) The expression of occludin
mRNA (I) and protein (J) in the lungs and the kidneys of wild-type and
homozygous mGS/mGS and mGS/GS KO mice. Both occludin mRNA (624-bp
fragment) and protein (∼66 kDa) were absent in both types of homozygous
mice, as detected by RT-PCR and Western blotting. L, lung; K, kidney.
(K) Pedigree showing the transmission of the targeted allele through three
generations. BDF1, C57BL/6×DBA/2. Scale bar=50 μm (B, C).
Fig. 2. Phenotypes of the occludin KOmice. (A) Body weights of the three types
of KO mice. All homozygous mice were significantly smaller than their wild-
type counterparts at 8 weeks of age (mean±SEM, n=4 to 18; ∗Pb0.05 by
t-test). (B–I) Histological appearance of the salivary gland (B, C), stomach (D,
E), femoral bone (F, G) and cerebrum (H, I) from 10-month-old wild-type and
homozygous KO mice. The KO mice had fewer cytoplasmic granules in their
salivary glands (C) and predominant hyperplasia in their gastric epithelia (E).
Trabecular development was also decreased (G) and mineral deposits (arrow-
heads) were observed in the cerebrum (I). Scale bar=50 μm (B, C), 100 μm (D–
G) and 250 μm (H, I).
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To examine whether GS and mGS cells can be used to
produce double KOs, GS and mGS cell clones that contained
a single targeted occludin gene were cultured with variousconcentrations of G418. Cell cultivation at a high concentra-
tion of G418 is a routine method for producing homozygous
KO ES cells (Mortensen et al., 1992). Although the mGS
cells were able to survive and proliferate at 20 mg/ml G418,
the GS cells were unable to survive when the concentration
of G418 exceeded 16 mg/ml; therefore, the selection process
was conducted at a lower G418 concentration for the GS
cells.
For the selection of mGS cell double KOs, a total of
5.4×106 targeted mGS cells (clone 118) were plated with
20 mg/ml G418, and 326 colonies were picked by micro-
manipulation, of which 203 clones were successfully
expanded. Of the 203 mGS cell clones that survived the
treatment with 20 mg/ml G418, two lost their heterozygosity,
as detected by Southern blot analysis using three different
probes (Fig. 4A). The frequency of double KO cell production
was slightly lower than that previously reported for experi-
ments with ES cells (1.0% vs. 4.2%) (Saitou et al., 1998). In
comparison, a total of 6.9×106 targeted GS cells (clone 101)
were plated at 8 mg/ml G418, 192 colonies were picked, and
141 clones were obtained. However, none of the GS cell
clones that survived the treatment with 8 mg/ml G418 showed
evidence of a loss of heterozygosity.
The two mGS cell clones retained their undifferentiated
morphology, and their growth rate was comparable to that of
the original clone with a single targeted allele. In agreement
with results from ES cells (Mortensen et al., 1992), both
mGS cell lines were able to tolerate a higher concentration
of G418 than the original clone. While mGS cells with a
single targeted allele produced 15 colonies at 20 mg/ml
G418, those with two targeted alleles produced 39 colonies,
suggesting that the latter expressed more neo mRNA and
protein (Fig. 4D).
To confirm the loss of occludin gene expression, we
analyzed the embryoid bodies produced by double KO mGS
cells cultured in suspension for 4 days. RT-PCR and Western
blot analyses showed no detectable occludin mRNA or
protein in the two mGS cell clones (Figs. 4B and C).
Nonetheless, both double KO cells retained the ability to
differentiate normally into somatic cells, and when these
mGS cell lines were transplanted subcutaneously, both clones
were able to differentiate into typical teratomas within
4 weeks. The tumors contained tissues from three germ
layers, such as neuron, heart muscle and tracheal epithelium
(Fig. 4E).
Finally, to examine whether the loss of heterozygosity in
the double KO cells was associated with chromosomal
aberrations, karyotype analysis was performed for two
G418-resistant clones (clones 25 and 131), with Hoechst
33258 banding after passage 26. The analysis revealed that,
although clone 131 maintained a euploid karyotype, only 20%
of clone 25 had 40 chromosomes (Fig. 4F). Further analysis of
clone 25 revealed that 76% of the cells were trisomic for
chromosome 11 (Fig. 4G). In addition, we found chromosomal
abnormalities in wild-type mGS cells following long-term
culture, including trisomy 8 and 11. The double KO clone 131
did not undergo any detectable translocations, additions or
Fig. 3. Impaired spermatogenesis and decreased fertility in homozygous KO
males. (A, B) Histological sections of wild-type mouse testis and epididymis at
9 months of age. Normal spermatogenesis was observed. (C–F) Histological
appearance of KO mouse testes and epididymides. At 10 weeks of age, normal
but decreased level of spermatogenesis was observed in the KO mice (C). Some
spermatozoa were contained in the epididymides of the young KO mice (D). In
contrast, at 9 months of age, the KO mice exhibited typical hypospermatogen-
esis (E), and no spermatozoa were observed in epididymides (F). (G) Reduced
fertility in homozygous GS/GS KO mice. Wild-type or KO males were caged
with wild-type females for 6 months, and the number of litters was recorded.
Homozygous KO males produced significantly fewer offspring (mean±SEM,
n=3; ∗Pb0.05 by t-test). Scale bar=50 mm (A–F).
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gene is located.
Discussion
To date the genetic manipulation of germline cells has been
limited to eggs or oocytes. KO animals are generally produced
by homologous recombination in ES cells (Nagy et al., 2003).
Alternatively, homologous recombination can be induced in
primary somatic cells, using the nucleus as a donor for nuclear
transplantation (McCreath et al., 2000). However, ES cells with
germline potential are only available in mice, and the techniques
used cannot be applied to animal species with fragile or low
numbers of oocytes. Genetic modification of the male germline
may solve these problems. Spermatogonial stem cells can serveas a vehicle for germline modification using retrovirus vectors
(Nagano et al., 2001; Hamra et al., 2002; Kanatsu-Shinohara et
al., 2004b); however, with the advent of GS cell culture
techniques, it is now possible to introduce homologous
recombination in spermatogonial stem cells to produce KO
animals (Kanatsu-Shinohara et al., 2006a). In this study, we
demonstrated a novel approach for male germline modification
using mGS cells. In contrast to GS cells, which contribute to the
germline by germ cell transplantation into seminiferous tubules,
mGS cells form germline chimeras by microinjection into
blastocysts (Kanatsu-Shinohara et al., 2004a). Nevertheless, the
phenotype of the mGS cell-derived KO mice was similar to
those produced by GS or ES cell-based methods. Our mGS cell-
based method is technically similar to ES cell-based approach
and represents the fourth method for producing KO animals.
KO mouse production using mGS cells demonstrates that
pluripotent stem cells from postnatal germ cells can be
genetically manipulated in a similar manner to ES cells from
early embryos. This was achieved despite the fact that these two
cell types have different patterns of genomic imprinting
(Kanatsu-Shinohara et al., 2004a). The mGS cells have partial
androgenetic imprinting, whereas the imprint patterns in ES
cells are similar to those found in somatic cells, although the
imprint patterns can change in both cell types during culture
(Dean et al., 1998; Kanatsu-Shinohara et al., 2004a). The level
of imprinting per se may not directly influence germ cell
commitment in pluripotent cells (Narashimha et al., 1997), but it
has a significant impact on somatic cell differentiation, which
limits the survival and reproductive performance of chimeric
animals. In fact, chimeras made with EG cells derived from
8.5 dpc PGCs had normal phenotypes, but those made with EG
cells derived from PGCs in the genital ridges exhibited skeletal
abnormalities and some died soon after birth (Labosky et al.,
1994; Tada et al., 1998; Durcova-Hills et al., 2001). These
results probably reflect the erasure of imprinting that occurs in
PGCs before migration into the gonads, and they also raise the
possibility that KO mice may not be produced with mGS cells
because of partial androgenetic imprinting patterns. That we
successfully produced KO mice using mGS cells indicates that
the epigenetic differences between ES and mGS cells may not
pose a significant barrier to germline modification.
Interestingly, we observed that mGS cells have the same
chromosomal defects that are frequently found in ES cells.
Several studies have shown that ES cells often become trisomic
for chromosome 8 or 11 during culture, and ES cells with these
abnormalities rarely achieve germline transmission (Liu et al.,
1997; Longo et al., 1997). Human ES cells often exhibit similar
non-random chromosomal abnormalities (Draper et al., 2004).
Such aneuploid cells usually outgrow normal euploid cells, and
the euploid nature of the karyotype correlates closely with the
level of chimerism, and it is aneuploidy more than the loss of
totipotency that is considered to be detrimental for germline
transmission in ES cells (Liu et al., 1997; Longo et al., 1997).
The occurrence of trisomy 8 and 11 during the culture of mGS
cells strongly suggests that the chromosomal abnormalities seen
in ES cells are not specific to ES cells and represent a more
common problem in pluripotent mouse stem cells.
Fig. 4. Derivation of double KO mGS cells. A heterozygous KO clone (clone
118) was used for double KO cell production. (A) Southern blot analysis of
DNA from the clones that survived G418 treatment. Genomic DNA was
digested with the indicated restriction enzymes and hybridized with three
different probes. The bands expected from the endogenous gene and resulting
from homologous recombination are indicated in Fig. 1A. (B, C) The lack of
occludin mRNA (B) and protein (C) in the double KO embryoid bodies, as
determined by RT-PCR and Western blotting, respectively. (D) Levels of G418
resistance in wild-type, heterozygous and homozygous mGS cells. Equal
numbers of wild-type, heterozygous KO and double KO mGS cells were plated
on G418-resistant MEFs and cultured with 20 mg/ml G418. The number of
surviving colonies was determined after 14 days of culture (mean±SEM, n=16;
Pb0.01 by t-test). (E) Histological section of a teratoma that developed from a
double KO mGS cells, showing tissues of three germ layers. Muscle (m), neural
(n) and epithelial (e) tissues were found. (F) Karyotype analysis of the cultured
cells. At least 20 cells were identified. (G) Types of aneuploid cells. At least 20
cells were counted. The chromosomal aberrations were confirmed by FISH
analysis. Scale bar=100 μm (E).
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the close similarities between ES and mGS cells. Homozygous
cells have been produced from heterozygous cultured cells by a
variety of means. In this study, we followed the scheme for the
selection of double KO ES cells production, and we found thatthose mGS cells that survived exposure to a high concentration
of G418 produced double KO cells. Although the mechanism of
double KO cell production in ES cells has long been unknown,
a recent report suggests that it occurs as a result of local
uniparental disomy or gene conversion between the targeted and
non-targeted loci (Lefebvre et al., 2001), and the same
mechanism probably applies to mGS cells. The feasibility of
double KO cell production from mGS cells may have important
implications in clinical application because these cells may be
used to produce differentiated somatic cells for regenerative
medicine. In particular, because mGS cells can be derived from
postnatal testes, this method may resolve the ethical problems
surrounding ES cell-based regenerative medicine.
On the other hand, GS cells were significantly more sensitive
to G418 than mGS cells, and we were unable to produce any
double KO GS cells using the same procedure. One possible
reason for the failure is inefficient selection of the GS cells
(Kanatsu-Shinohara et al., 2005b), which may be improved by
optimizing our growth conditions. However, given the fact that
GS cells maintain normal karyotypes after long-term culture
(Kanatsu-Shinohara et al., 2005a), we speculate that the
configuration and/or stability of the chromosomes are sig-
nificantly different between pluripotent stem cells and tissue-
specific stem cells, and that GS cells have greater chromosomal
stability, thereby preventing the spontaneous loss of hetero-
zygosity observed in pluripotent ES/mGS cells. Further
characterization of GS cells will be required to examine this
possibility.
Despite the close similarities between our approach and the
ES cell-based method, improvements must be made to increase
the usefulness of our technique. A major obstacle in the
germline modification of mGS cells was chimera production. It
is known that 129 ES cells contribute more to the somatic and
germline tissues in the chimeras than the C57BL/6 component
(Papaioannou and Behringer, 2005). In this study, we micro-
injected DBA/2 mGS cells into C57BL/6×DBA/2 blastocysts,
and one of the seven animals analyzed was identified a germline
chimera. The donor cell contribution to coat color was low in
this animal; however, this was successfully overcome by
microinsemination in our experiments. Finding more suitable
host will likely improve germline transmission. Another
potentially important parameter is the stability of the germline
potential in vitro. Different levels of germline transmission are
achieved using different ES cell lines (Nagy et al., 2003;
Papaioannou and Behringer, 2005). While euploidy is one
factor that influences the germline stability, the culture
conditions of the ES cells also influences the maintenance of
germline potential; serum-free medium generally produces
better outcomes (Goldsborough et al., 1998). Additional studies
will provide important information to improve this technology.
A clear advantage of the current technique for KO mouse
production is the use of different genetic backgrounds. While
ES cells are derived almost exclusively from preimplantation
embryos in a 129 background, mGS cells as well as EG cells
can be derived not only from cells at later stages of
development, but they are also available in several backgrounds
(Matsui et al., 1992; Resnick et al., 1992; Kanatsu-Shinohara et
351M. Takehashi et al. / Developmental Biology 312 (2007) 344–352al., 2004a). Although improvements in ES culture conditions
have led to the derivation of ES cells in several other inbred
backgrounds (Schoonjans et al., 2003), only limited number of
gene targeting studies have used these cells, suggesting that 129
has a more stable germline potential. The difference in germline
stability may simply reflect genetic differences, but it is also
possible that the mechanism or origin of pluripotent cell
derivation may significantly impact the stability of its germline
potential. Indeed, it is possible that mGS cells achieve higher
germline transmission rates than ES cells because of their germ
cell origin. Whatever the mechanism involved, the use of
different genetic backgrounds is advantageous in mouse
functional genomics because otherwise substantial backcross-
ing is necessary to obtain mutant animals with inbred genetic
backgrounds that can be used to study gene functions (Seong
et al., 2004).
An important question that must be addressed in the future is
whether this technique can be extended to other animal species.
ES-like cells from testes have been reported not only in mice but
also in other species, including humans (Cyranoski, 2006; Jung
et al., 2007). However, considering the close similarity between
ES and mGS cells and the fact that only mouse ES cells have
germline potential, the technology described here may not be
applicable to animals other than mice. Nevertheless, the results
of a recent study suggest that spermatogonial stem cells have
more flexible differentiation potential than ES cells. Pluripotent
cells from adult spermatogonia (i. e. multipotent adult germline
stem cells) achieved germline transmission following micro-
injection either into the seminiferous tubules or the blastocyst
cavity (Guan et al., 2006). This result was unexpected because
previous attempts to demonstrate germline transmission by
injection into seminiferous tubules failed with ES and mGS
cells (Brinster and Avarbock, 1994; Kanatsu-Shinohara et al.,
2004a). Therefore, a spermatogonia-based approach may
resolve critical problems with ES cell technology. More
extensive studies are clearly required to determine whether
mGS cells can also undergo germline transmission by germ cell
transplantation and whether the pluripotent cells from sperma-
togonia are a better vehicle for germline modification than ES
cells.
Genetic modification of spermatogonial stem cells provides
a new opportunity for germline manipulation. Spermatogonial
stem cells can be cultured in the absence of serum or feeder cells
(Kanatsu-Shinohara et al., 2005c, 2006b), and they produce
offspring following xenogeneic transplantation into smaller
surrogate animals (Shinohara et al., 2006). The current study
demonstrates the feasibility of KO mouse production using
mGS cells. Hopefully, this technique will be useful for the
germline modification in animal species, in which genetic
manipulation is very difficult or impossible.
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